We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
Steve Stecklow, 42, rallied to the Government’s call in July for people to participate in large-scale clinical trials. Steve became one of 10,000 Britons selected by US biotech firm Novavax Inc NVAX.O to determine the vaccine’s effectiveness. Journalist Steve said: “I began researching the Novavax vaccine, which has received less attention than several others. It seemed less risky. It’s employing the same technology to create its Covid-19 candidate it used with a promising flu shot.”
The first phase showed no serious side effects among 100 participants at King’s College Hospital in south London with just one person experiencing a mild fever.
Steve added: “I figured if life is ever going to return to normal, the world is going to need vaccines and volunteers to see if they work. I liked the idea of getting inoculated as soon as possible, given how monotonous – and sometimes scary – my daily routine had become.
“I’ve become so risk-averse that my wife has called me her jailer.”
Steve said another attraction was that if he got the virus he would receive close monitoring rather than being told to self-isolate.
He added: “So far, I’ve experienced no side effects.”
Source: Read Full Article